Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial

Mona Fiuzat, Daniel Wojdyla, Ileana L. Pina, Kirkwood Adams, David Whellan, Christopher M. O'Connor

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objectives: This study aimed to compare whether reduced heart rate (HR) or higher beta-blocker (BB) dose affected outcomes to a greater extent in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial population. Background: Recent data have shown that HR is an important modifiable factor in reducing mortality in heart failure (HF) patients. It has also been shown that titration of doses of BBs improves outcomes of morbidity and mortality in chronic HF patients with reduced ejection fraction. We aimed to compare whether reduced HR or higher BB dose affected outcomes to a greater extent in the HF-ACTION trial population. Methods: HF-ACTION was a randomized, multicenter trial enrolling 2,331 ambulatory HF patients with systolic dysfunction (New York Heart Association functional class II to IV, left ventricular ejection fraction

Original languageEnglish (US)
Pages (from-to)109-115
Number of pages7
JournalJACC: Heart Failure
Volume4
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Heart Failure
Heart Rate
Exercise
Mortality
Stroke Volume
Population
Multicenter Studies
Morbidity

Keywords

  • Beta-blockers
  • Dose
  • Exercise
  • Heart failure
  • Heart rate
  • Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction : Results From the HF-ACTION Trial. / Fiuzat, Mona; Wojdyla, Daniel; Pina, Ileana L.; Adams, Kirkwood; Whellan, David; O'Connor, Christopher M.

In: JACC: Heart Failure, Vol. 4, No. 2, 01.02.2016, p. 109-115.

Research output: Contribution to journalArticle

Fiuzat, Mona ; Wojdyla, Daniel ; Pina, Ileana L. ; Adams, Kirkwood ; Whellan, David ; O'Connor, Christopher M. / Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction : Results From the HF-ACTION Trial. In: JACC: Heart Failure. 2016 ; Vol. 4, No. 2. pp. 109-115.
@article{13882d8f685f4b7982b19a5fbf3af7b1,
title = "Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial",
abstract = "Objectives: This study aimed to compare whether reduced heart rate (HR) or higher beta-blocker (BB) dose affected outcomes to a greater extent in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial population. Background: Recent data have shown that HR is an important modifiable factor in reducing mortality in heart failure (HF) patients. It has also been shown that titration of doses of BBs improves outcomes of morbidity and mortality in chronic HF patients with reduced ejection fraction. We aimed to compare whether reduced HR or higher BB dose affected outcomes to a greater extent in the HF-ACTION trial population. Methods: HF-ACTION was a randomized, multicenter trial enrolling 2,331 ambulatory HF patients with systolic dysfunction (New York Heart Association functional class II to IV, left ventricular ejection fraction",
keywords = "Beta-blockers, Dose, Exercise, Heart failure, Heart rate, Mortality",
author = "Mona Fiuzat and Daniel Wojdyla and Pina, {Ileana L.} and Kirkwood Adams and David Whellan and O'Connor, {Christopher M.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.jchf.2015.09.002",
language = "English (US)",
volume = "4",
pages = "109--115",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

T2 - Results From the HF-ACTION Trial

AU - Fiuzat, Mona

AU - Wojdyla, Daniel

AU - Pina, Ileana L.

AU - Adams, Kirkwood

AU - Whellan, David

AU - O'Connor, Christopher M.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Objectives: This study aimed to compare whether reduced heart rate (HR) or higher beta-blocker (BB) dose affected outcomes to a greater extent in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial population. Background: Recent data have shown that HR is an important modifiable factor in reducing mortality in heart failure (HF) patients. It has also been shown that titration of doses of BBs improves outcomes of morbidity and mortality in chronic HF patients with reduced ejection fraction. We aimed to compare whether reduced HR or higher BB dose affected outcomes to a greater extent in the HF-ACTION trial population. Methods: HF-ACTION was a randomized, multicenter trial enrolling 2,331 ambulatory HF patients with systolic dysfunction (New York Heart Association functional class II to IV, left ventricular ejection fraction

AB - Objectives: This study aimed to compare whether reduced heart rate (HR) or higher beta-blocker (BB) dose affected outcomes to a greater extent in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial population. Background: Recent data have shown that HR is an important modifiable factor in reducing mortality in heart failure (HF) patients. It has also been shown that titration of doses of BBs improves outcomes of morbidity and mortality in chronic HF patients with reduced ejection fraction. We aimed to compare whether reduced HR or higher BB dose affected outcomes to a greater extent in the HF-ACTION trial population. Methods: HF-ACTION was a randomized, multicenter trial enrolling 2,331 ambulatory HF patients with systolic dysfunction (New York Heart Association functional class II to IV, left ventricular ejection fraction

KW - Beta-blockers

KW - Dose

KW - Exercise

KW - Heart failure

KW - Heart rate

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=84959099950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959099950&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2015.09.002

DO - 10.1016/j.jchf.2015.09.002

M3 - Article

C2 - 26519996

AN - SCOPUS:84959099950

VL - 4

SP - 109

EP - 115

JO - JACC: Heart Failure

JF - JACC: Heart Failure

SN - 2213-1779

IS - 2

ER -